Correction to: Concurrent management of multiple sclerosis and natalizumab‑induced hepatitis with ofatumumab: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Correction to: Concurrent management of multiple sclerosis and natalizumab‑induced hepatitis with ofatumumab: a case report ; volume:45 ; number:10 ; day:17 ; month:7 ; year:2024 ; pages:5115 ; date:10.2024
Neurological sciences ; 45, Heft 10 (17.7.2024), 5115, 10.2024
- Creator
-
Haggiag, Shalom
Giannelli, Valerio
Prosperini, Luca
Cruciani, Alessandro
Baiocchini, Andrea
Ruggieri, Serena
Pellicelli, Adriano
Gasperini, Claudio
Tortorella, Carla
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-024-07694-3
- URN
-
urn:nbn:de:101:1-2412102124573.145960218211
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Haggiag, Shalom
- Giannelli, Valerio
- Prosperini, Luca
- Cruciani, Alessandro
- Baiocchini, Andrea
- Ruggieri, Serena
- Pellicelli, Adriano
- Gasperini, Claudio
- Tortorella, Carla
- SpringerLink (Online service)
Other Objects (12)
Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Concurrent gliomas in patients with multiple sclerosis
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Concurrent gliomas in patients with multiple sclerosis
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Concurrent gliomas in patients with multiple sclerosis
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study